Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts

• Published in: Annals of plastic surgery Vol. 33; no. 2; p. 148
• Main Authors: Younai, S, Nichter, L S, Wellisz, T, Reinisch, J, Nimni, M E, Tuan, T L
• Format: Journal Article
• Language: English
• Published: United States 01-08-1994
• Subjects: Antibodies - pharmacology; Cells, Cultured; Cicatrix, Hypertrophic - metabolism; Cicatrix, Hypertrophic - pathology; Collagen - biosynthesis; Fibroblasts - drug effects; Fibroblasts - metabolism; Humans; In Vitro Techniques; Keloid - metabolism; Keloid - pathology; Skin - cytology; Time Factors; Transforming Growth Factor beta - immunology; Transforming Growth Factor beta - pharmacology; Wound Healing - physiology
• ISSN: 0148-7043
• DOI: 10.1097/00000637-199408000-00005

Keloid and hypertrophic scars are fibrous growths characterized by overabundant collagen deposition. We examined the effect of transforming growth factor-beta (TGF-beta), a known stimulant for the production of connective tissue matrices, on the rate of collagen synthesis in keloid fibroblasts (KFs), hypertrophic scar fibroblasts (HSFs), and normal skin fibroblasts (NSFs). Fibroblasts were cultured in three-dimensional fibrin-gel matrices in the presence or absence of TGF-beta (5 ng/ml) or anti-TGF-beta neutralizing antibody (50 micrograms/ml). Secreted collagen levels, labeled with 3H-proline, were measured after 48 hours. KFs produced up to 12 times more collagen than NSFs, and up to 4 times more than HSFs. Although KFs increased their rate of collagen production by up to 2.7 times in response to TGF-beta, HSFs and NSFs did not (p = 0.065). Anti-TGF-beta antibody reduced the rate of collagen synthesis of KFs by 40% (p = 0.003), although it did not suppress collagen production in HSFs (p = 0.06) and NSFs (p = 0.75). We conclude that although KFs and HSFs are similar in that they both overproduce collagen, they are different in that only KFs display a marked sensitivity to TGF-beta, which is abundant during the proliferative phase of wound healing.